Biggest shake-up in type 2 diabetes care in a decade announced
On Aug. 20, 2025, the National Institute for Health and Care Excellence (NICE) announced that millions of people…
Biotechnology | Disease | FDA | Medicine | Therapeutics
Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients
On Aug. 18, 2025, Novo Nordisk announced the launch of a new offer that enables self-paying, eligible, type…
Implantable device could save diabetes patients from dangerously low blood sugar
On Jul. 9, 2025, MIT engineers announced they have designed an implantable reservoir that can remain under the…
Vertex Reports Positive Data for Zimislecel in Type 1 Diabetes
On Jun. 20, 2025, Vertex Pharmaceuticals announced publication of updated data from the Phase 1/2 portion of the…
‘Artificial pancreas’ transforming the lives of thousands of children and young people with type 1 diabetes
On Jun. 16, 2025, the National Institute for Health and Care Excellence (NICE) announced that the recommendation in…
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub
On May 12, 2025, Roche announced it plans to invest up to $550 million in its Diagnostics site…
More than half of adults and a third of children and adolescents predicted to have overweight or obesity by 2050
On Mar. 3, 2025, the Institute for Health Metrics and Evaluation reported that without urgent policy reform and…
FDA declares Wegovy® and Ozempic® shortage is over and Supply now exceeds nationwide demand
On Feb. 21, 2025, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has determined the…
Biotechnology | Disease | FDA | Neurology | Ophthalmogy | Therapeutics
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
On Feb. 4, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Susvimo® (ranibizumab…
Biotechnology | Disease | FDA | Therapeutics
FDA approves Ozempic® (semaglutide) as only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and CKD
On Jan. 28, 2025, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic® to…
huge study highlights new health risks of Obesity drugs
On Jan. 20, 2025, an analysis of data from nearly 2 million people has revealed new insights into…
United States Dementia Cases Estimated to Double by 2060
On Jan. 13, 2025, a study led by NYU Langone Health shows that the risk of developing dementia at…
FDA Approved First Medication for Obstructive Sleep Apnea
On Dec. 20, 2024, the U.S. Food and Drug Administration (FDA) approved Eli Lilly’s Zepbound (tirzepatide) for the…
Agriculture | Biotechnology | Chemical | Environmental | FDA
FDA updates Definition of “Healthy Foods” For Packaging, first time in three decades
On Dec. 19, 2024, the U.S. Food and Drug Administration announced it had updated the definition of “healthy…
AARP and Leading Research Organizations Announced Risk Factors of Dementia Research Findings
On Nov. 15, 2024, the AARP, the Alzheimer’s Disease Data Initiative (AD Data Initiative), and the Institute for…
Urgent action needed as global diabetes cases increase four-fold over past decades
On Nov. 13, 2024, the NCD Risk Factor Collaboration (NCD-RisC) with support from the World Health Organization (WHO)…
Artificial Intelligence | Biotechnology | Diagnostics | Genomics | Infectious Disease | Therapeutics | Vaccine
UW–Madison researchers find persistent problems with AI-assisted genomic studies
On Nov. 4, 2024, a team of University of Wisconsin–Madison researchers warned that artificial intelligence tools gaining popularity…
Restricting sugar before birth and in early childhood greatly reduces risk of chronic disease later in life
On Nov. 1, 2024, researchers reported results from a study that show a low-sugar diet during pregnancy and…
Tuberculosis resurges as top infectious disease killer
On Oct. 29, 2024, the World Health Organization (WHO) published a report on tuberculosis revealing that approximately 8.2…
Stem cells reverse woman’s diabetes — a world first
On Sept. 26, 2024, a team of scientists in Peking University in Beijing, China announced that a 25-year-old…
Cleveland Clinic Study Identified Key Factors That Can Impact Long-Term Weight Loss in Patients with Obesity Prescribed GLP-1 RA Medications
On Sep. 13, 2024, a Cleveland Clinic study was announced that identified key factors that can impact the…
Study Revealed How COVID-19 Infection Can Cause or Worsen Diabetes
On Sept. 13, 2024, researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the…
Human ‘Molecular Map’ Contributes to the Understanding of Disease Mechanisms
On Sep. 10, 2024, researchers at Weill Cornell Medicine in Qatar announced they had created a free-to-access online…
Lilly opened state-of-the-art research and development center in the Boston Seaport
On Aug. 13, 2024, Eli Lilly announced the opening of the Lilly Seaport Innovation Center (LSC), a research…
Biotechnology | Diagnostics | Disease | Oncology | Therapeutics | WHO
Nearly 1.8 billion adults at risk of disease from not doing enough physical activity
On Jun. 26. 2024, the World Health Organization reported that new data show that nearly one third (31%)…
In a first, genetically edited pig kidney was transplanted into a human
On Mar. 21, 2024, Harvard Medical School physician-scientists at Massachusetts General Hospital announced they had successfully transplanted a…
Biotechnology | Disease | FDA | Therapeutics
FDA approved first treatment for patients with liver scarring due to fatty liver disease
On Mar. 14, 2024, the U.S. Food and Drug Administration (FDA) approved Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the…
University of Illinois and Universidade de Sao Paulo develop first transgenic cow to produce human insulin in her milk
On Mar. 13, 2024, an unassuming brown bovine from the south of Brazil has made history as the…
Biotechnology | FDA | Therapeutics | Vaccine
Wegovy received FDA approval for cardiovascular risk reduction in adults with known heart disease or obesity
On Mar. 8, 2024, the U.S. Food and Drug Administration approved a new indication for use of Novo…
Biotechnology | Diagnostics | Disease | FDA | Medical Device
FDA cleared first Over-the-Counter continuous glucose monitor
On Mar. 5, 2024, the U.S. Food and Drug Administration (FDA) cleared for marketing the first over-the-counter (OTC)…